References - Therapeutic Strategies in Cancer Biology and Pathology - page 200

Cabello, C.M., Qiao, S., Bair III, W.B., Davis, A.L., Lesson, J.L., Wondrak, G.T., 2010. GLO1
Downregulation in human renal cell carcinoma enables targeted chemotherapeutic intervention
using methylglyoxal as cytotoxic heat shock inducer. Free Radic. Biol. Med. 49, S73-S74.
Cadenas, C., Franckenstein, D., Schmidt, M., Gehrmann, M., Hermes, M., Geppert, B., et al.,
2010. Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of
breast cancer. Breast Cancer Res. 12, R44.
Cai, C., Ashktorab, H., Pang, X., Zhao, Y., Sha, W., Liu, Y., et al., 2012. MicroRNA-211
expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor
suppressor CHD5. PLoS ONE 7, e29750.
Cajone, F., Sherbet, G.V., 1999. Stathmin is involved in S100A4-mediated regulation of cell
cycle progression. Clin. Exp. Metastasis 17, 865-871.
Caldwell, G.M., Jones, C., Gensberg, K., Jan, S., Hardy, R.G., Byrd, P., et al., 2004. The Wnt
antagonist sFRP1 in colorectal tumorigenesis. Cancer Res. 64, 883-888.
Camps, C., Buffa, F.M., Colella, S., Moore, J., Sotiriou, C., Sheldon, H., et al., 2008. hsa-
miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer.
Clin. Cancer Res. 14, 1340-1348.
Cao, L., Bombard, J., Cintron, K., Sheedy, J., Weetall, M.L., Davis, T.W., 2011. BMI1 as a
novel target for drug discovery in cancer. J. Cell. Biochem. 112, 2729-2741.
Caplen, N.J., 2004. Gene therapy progress and prospects. Down regulating gene expression:
the impact of RNA interference. Gene Ther. 11, 1241-1248.
Carey, J.P.W., Asirvatham, A.J., Galm, O., Ghogomu, T.A., Chaudhary J. 2009. Inhibitor of
differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer. BMC Cancer 9,
Art. no. 173.
Carletti, M.Z., Fiedler, S.D., Christenson, L.K., 2010. MicroRNA 21 blocks apoptosis in
mouse periovulatory granulosa cells. Biol. Reprod. 83, 286-295.
Carmell, M.A., Hannon, G.J., 2004. RNase III enzymes and the initiation of gene silencing.
Nat. Struct. Mol. Biol. 11, 214-218.
Carney, J.P., Maser, R.S., Olivares, H., Davis, E.M., Le Beau, M., Yates III, J.R., et al., 1998.
The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of dou-
ble-strand break repair to the cellular DNA damage response. Cell 93, 477-486.
Carson-Walter, E.B., Nanda, A., Vogelstein, B., Kinzler, K.W., Croix, B.S., 2001. Cell sur-
face tumor endothelial markers are conserved in mice and humans. Cancer Res. 61,
6649-6655.
Casas, E., Kim, J., Bendesky, A., Ohno-Machado, L., Wolfe, C.J., Yang, J., 2011. Snail2 is an
essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis.
Cancer Res. 71, 245-254.
Castano, J.P., Martinez-Fuentes, A.J., Gutierrez-Pascual, E., Vaudry, H., Tena-Sempere, M.,
Malagon, M.M., 2009. Intracellular signaling pathways activated by kisspeptins through
GPR54: do multiple signals underlie function diversity? Peptides 30, 10-15.
Cecchinato, V., Chiaramonte, R., Nizzardo, M., Cristofaro, B., Basile, A., Sherbet, G.V., et al.,
2007. Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia
MOLT-4 cells. Biochem. Pharmacol. 74, 1568-1574.
Cella, N., Contreras, A., Latha, K., Rosen, J.M., Zhang, M., 2006. Maspin is physically asso-
ciated with β1 integrin regulating cell adhesion in mammary epithelial cells. FASEB J.
20, 1510-1512.
Cengiz, B., Gunduz, E., Gunduz, M., Beder, L.B., Tamamura, R., Bagci, C., et al., 2010.
Tumor-specific mutation and downregulation of ING5 detected in oral squamous cell car-
cinoma. Int. J. Cancer 127, 2088-2094.